CircRNAs: biogenesis, functions, and role in drug-resistant Tumours DOI Creative Commons
Shuo Ma,

Shan Kong,

Feng Wang

et al.

Molecular Cancer, Journal Year: 2020, Volume and Issue: 19(1)

Published: Aug. 5, 2020

Abstract Targeted treatment, which can specifically kill tumour cells without affecting normal cells, is a new approach for therapy. However, tend to acquire resistance targeted drugs during treatment. Circular RNAs (circRNAs) are single-stranded RNA molecules with unique structures and important functions. With the development of sequencing technology, circRNAs have been found be widespread in tumour-resistant play regulatory roles. In this review, we present latest advances circRNA research summarize various mechanisms underlying their regulation. Moreover, review role chemotherapeutic tumours explore clinical value regulation treating resistance.

Language: Английский

Long non-coding RNAs: definitions, functions, challenges and recommendations DOI Open Access
John S. Mattick, Paulo Amaral, Piero Carninci

et al.

Nature Reviews Molecular Cell Biology, Journal Year: 2023, Volume and Issue: 24(6), P. 430 - 447

Published: Jan. 3, 2023

Language: Английский

Citations

1207

The role of microenvironment in tumor angiogenesis DOI Creative Commons

Xianjie Jiang,

Jie Wang, Xiangying Deng

et al.

Journal of Experimental & Clinical Cancer Research, Journal Year: 2020, Volume and Issue: 39(1)

Published: Sept. 30, 2020

Abstract Tumor angiogenesis is necessary for the continued survival and development of tumor cells, plays an important role in their growth, invasion, metastasis. The microenvironment—composed surrounding secreted cytokines—provides a conducive environment growth tumors. Different components microenvironment can regulate development. In this review, we have discussed regulatory angiogenesis. High expression angiogenic factors inflammatory cytokines microenvironment, as well hypoxia, are presumed to be reasons poor therapeutic efficacy current anti-angiogenic drugs. A combination drugs antitumor or hypoxia inhibitors might improve outcome.

Language: Английский

Citations

512

Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy DOI Creative Commons
Yuanjun Lu,

Yau-Tuen Chan,

Hor‐Yue Tan

et al.

Molecular Cancer, Journal Year: 2020, Volume and Issue: 19(1)

Published: April 27, 2020

Abstract Epigenetics is dynamic and heritable modifications to the genome that occur independently of DNA sequence. It requires interactions cohesively with various enzymes other molecular components. Aberrant epigenetic alterations can lead inappropriate onset genetic expressions promote tumorigenesis. As modifiers are susceptible extrinsic factors reversible, they becoming promising targets in multiple cancer therapies. Recently, epi-drugs have been developed implicated clinical use. The use alone, or combination chemotherapy immunotherapy, has shown compelling outcomes, including augmentation anti-tumoral effects, overcoming drug resistance, activation host immune response.

Language: Английский

Citations

388

Targeting circular RNAs as a therapeutic approach: current strategies and challenges DOI Creative Commons
Alina T. He, Jinglei Liu, Feiya Li

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2021, Volume and Issue: 6(1)

Published: May 21, 2021

Abstract Significant progress has been made in circular RNA (circRNA) research recent years. Increasing evidence suggests that circRNAs play important roles many cellular processes, and their dysregulation is implicated the pathogenesis of various diseases. CircRNAs are highly stable usually expressed a tissue- or cell type-specific manner. Therefore, they currently being explored as potential therapeutic targets. Gain-of-function loss-of-function approaches typically performed using circRNA expression plasmids interference-based strategies, respectively. These strategies have limitations can be mitigated nanoparticle exosome delivery systems. Furthermore, developments show cre-lox system used to knockdown cell-specific While still early stages development, CRISPR/Cas13 shown promise knocking down with high specificity efficiency. In this review, we describe properties functions highlight significance disease. We summarize overexpress approach. Lastly, discuss major challenges propose future directions for development circRNA-based therapeutics.

Language: Английский

Citations

386

Intestinal Flora and Disease Mutually Shape the Regional Immune System in the Intestinal Tract DOI Creative Commons
Bolun Zhou, Yutong Yuan, Shan Zhang

et al.

Frontiers in Immunology, Journal Year: 2020, Volume and Issue: 11

Published: April 3, 2020

The intestinal tract is the largest digestive organ in human body. It colonized by, and consistently exposed to, a myriad of microorganisms, including bifidobacteria, lactobacillus, Escherichia coli, enterococcus, clostridium perfringens, pseudomonas. To protect body from potential pathogens, has evolved regional immune characteristics. These characteristics are defined by its unique structure, function, microenvironment, which differ drastically those common central peripheral organs. microenvironment created flora products significantly affects function region. In turn, specific diseases regulate influence composition flora. A constant interplay occurs between system. Further, can be reconstructed probiotic use or microbiota transplantation, functioning to recalibrate homeostasis, while also contributing treatment amelioration diseases. this review, we summarize relationship occurrence development as an in-turn effect on immunity. We discuss improved it relates non-specific proliferation, differentiation secretion cells, within region following remodeling means ameliorate treat Finally, suggest strategies for utilization

Language: Английский

Citations

279

Roles and mechanisms of exosomal non-coding RNAs in human health and diseases DOI Creative Commons
Chen Li, Yu‐Qing Ni, Hui Xu

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2021, Volume and Issue: 6(1)

Published: Nov. 10, 2021

Exosomes play a role as mediators of cell-to-cell communication, thus exhibiting pleiotropic activities to homeostasis regulation. Exosomal non-coding RNAs (ncRNAs), mainly microRNAs (miRNAs), long (lncRNAs), and circular (circRNAs), are closely related variety biological functional aspects human health. When the exosomal ncRNAs undergo tissue-specific changes due diverse internal or external disorders, they can cause tissue dysfunction, aging, diseases. In this review, we comprehensively discuss underlying regulatory mechanisms exosomes in addition, explore current knowledge on roles miRNAs, lncRNAs, circRNAs health diseases, including cancers, metabolic neurodegenerative cardiovascular autoimmune infectious determine their potential implication biomarker identification therapeutic exploration.

Language: Английский

Citations

274

Single‐cell RNA sequencing in cancer research DOI Creative Commons
Yijie Zhang, Dan Wang, Peng Miao

et al.

Journal of Experimental & Clinical Cancer Research, Journal Year: 2021, Volume and Issue: 40(1)

Published: March 1, 2021

Abstract Single-cell RNA sequencing (scRNA-seq), a technology that analyzes transcriptomes of complex tissues at single-cell levels, can identify differential gene expression and epigenetic factors caused by mutations in unicellular genomes, as well new cell-specific markers cell types. scRNA-seq plays an important role various aspects tumor research. It reveals the heterogeneity cells monitors progress development, thereby preventing further cellular deterioration. Furthermore, transcriptome analysis immune tissue be used to classify cells, their escape mechanisms drug resistance mechanisms, develop effective clinical targeted therapies combined with immunotherapy. Moreover, this method enables study intercellular communication interaction non-malignant reveal carcinogenesis. provides technical means for development research is expected make significant breakthroughs field. This review focuses on principles scRNA-seq, emphasis application heterogeneity, pathogenesis, treatment.

Language: Английский

Citations

257

lncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions DOI
Evan M. McCabe, Theodore P. Rasmussen

Seminars in Cancer Biology, Journal Year: 2020, Volume and Issue: 75, P. 38 - 48

Published: Dec. 18, 2020

Language: Английский

Citations

240

The small peptide world in long noncoding RNAs DOI Creative Commons

Seowon Choi,

Hyunwoo Kim, Jin‐Wu Nam

et al.

Briefings in Bioinformatics, Journal Year: 2018, Volume and Issue: 20(5), P. 1853 - 1864

Published: May 31, 2018

Abstract Long noncoding RNAs (lncRNAs) are a group of transcripts that longer than 200 nucleotides (nt) without coding potential. Over the past decade, tens thousands novel lncRNAs have been annotated in animal and plant genomes because advanced high-throughput RNA sequencing technologies with aid transcript classifiers. Further, considerable number reports revealed existence stable, functional small peptides (also known as micropeptides), translated from lncRNAs. In this review, we discuss methods lncRNA classification, investigations regarding their potential significance they encode.

Language: Английский

Citations

232

Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics DOI

Susi Zhu,

Yeye Guo, Xu Zhang

et al.

Cancer Letters, Journal Year: 2020, Volume and Issue: 503, P. 240 - 248

Published: Nov. 24, 2020

Language: Английский

Citations

165